Atrial Fibrillation Clinical Trials in Seoul
14 recruitingSeoul, South Korea
Showing 1–14 of 14 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
PulseSelect™ PFA Global Registry
Atrial Fibrillation
Medtronic Cardiac Ablation Solutions1,950 enrolled28 locationsNCT06393920
Recruiting
Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
Atrial FibrillationStroke
Population Health Research Institute2,270 enrolled105 locationsNCT03968393
Recruiting
Not Applicable
Application-Based Integrated Care in Patients After Pulse Field Ablation
Atrial Fibrillation Patients Treated With the FARAPULSE™ PFA System
Yonsei University500 enrolled1 locationNCT07119528
Recruiting
Not Applicable
Effect of Left Posterior Pericardiotomy for the Prevention of POAF
Coronary Artery DiseaseAtrial Fibrillation New OnsetPericardial Effusion
Seoul National University Hospital270 enrolled1 locationNCT06159985
Recruiting
Not Applicable
Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
Paroxysmal Atrial Fibrillation
Seoul National University Hospital150 enrolled1 locationNCT05996159
Recruiting
Phase 4
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)
Atrial Fibrillation Patients With Intermediate Stroke Risk
Yonsei University1,800 enrolled1 locationNCT04437654
Recruiting
Not Applicable
Computed Tomogram Myocardial Thickness Map Guided pulmOnary Vein iSolaTion vs. Empirical Pulmonary Vein Isolation in Cryoballoon Ablation for Paroxysmal Atrial Fibrillation (UTMOST AF II)
Paroxysmal Atrial Fibrillation
Yonsei University220 enrolled1 locationNCT03912324
Recruiting
Not Applicable
Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation
Atrial Fibrillation
Seoul National University Hospital400 enrolled1 locationNCT06216769
Recruiting
Phase 4
Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation
Atrial FibrillationAnticoagulant Adverse Reaction
Korea University Anam Hospital940 enrolled1 locationNCT06187311
Recruiting
Not Applicable
Artificial Intelligence Guided Patient Selection for Atrial Fibrillation Catheter Ablation: Randomized Clinical Trial (AI-PAFA Trial)
Atrial Fibrillation
Yonsei University1,000 enrolled1 locationNCT04997824
Recruiting
Phase 4
AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation
Yonsei University840 enrolled1 locationNCT04432220
Recruiting
Not Applicable
Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Virtual Rotor Mapping and Catheter Ablation
Paroxysmal Atrial Fibrillation
Yonsei University110 enrolled1 locationNCT02558699
Recruiting
The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study
Atrial Fibrillation
Yonsei University3,100 enrolled1 locationNCT02138695